9lione, Inc.

Private

TokyoHealthcare & Life Scienceshttps://www.9lione.net/

Last Round

Series B

Dec 25, 2023

Est. Valuation

$11.4M

Total Funding Raised

$828,000

Company Overview

9lione, Inc. is a healthcare technology company that develops cloud-based medical supply and pharmaceutical inventory management systems for pharmacies and medical institutions.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, Vertical SaaS, Supply Chain

Business Model

B2B

Customer Profile

Subscription SaaS, Marketplace Commission

AI Layer

Application

Keywords

pharmaceutical inventory managementhealthcare SaaSpharma supply chaindigital transformationDXmedical inventory softwarepharmacy management systemOCR technologydemand forecastingsecondary distribution marketplacemedical waste reductionmedtechhealthtechinventory automationB2B healthcare

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

9lione, Inc. Comps

Public and private peers based on sector, stage, and business model.

9lione, Inc. comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

9lione, Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	Dec 25, 2023
Seed	Jun 30, 2021
Accelerator	Oct 1, 2018

View all Funding Rounds

9lione, Inc. Investors

Notable investors and investment history

9lione, Inc. investors
Investor	Rounds
Open Network Lab	Accelerator
DG Ventures	Series B
Yokohama Capital Co., Ltd.	Series B
Mitsui Sumitomo Insurance Capital Co., Ltd.	Series B
Incubate Fund	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Dec 25, 2023
$828K round with participation from DG Ventures and Mitsui Sumitomo Insurance Capital.

View all signals

9lione, Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

9lione, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about 9lione, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTokyo

Employee Range1

Year Founded2018

Last FundingDec 25, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.